用于胃潰瘍管理的素涂層 hesperidin 納米粒子的生物評估
Naveed Ullah Khan1, Anam Razzaq2, Zhang Rui1
1College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310012, China.
Colloids and surfaces. B, Biointerfaces
|January 20, 2024
概括
素涂层 hesperidin 纳米载体 (Se-He-NLCs) 通过改善药物输送和减少炎症,有效地治愈胃. 这种新的方法提高了生物可用性,并促进了胃内膜的修复,以获得更好的治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃潰瘍在目前的治療方法中存在重大挑戰.
- 赫斯佩里丁是一种黄类化合物,由于其抗炎和抗氧化特性,它对愈有前途.
研究的目的:
- 开发和表征素涂层的素荷载纳米脂质载体 (Se-He-NLCs) 用于增强胃治疗.
- 评估Se-He-NLCs在促进愈和保护胃内膜方面的体外和体内疗效.
主要方法:
- 纳米脂质载体 (NLC) 配备了hesperidin,并涂上了sericin.
- 物理化学表征包括药物加载,封装效率,颗粒大小,形态和药物释放研究.
- 进行了体外透,体外粘粘结和体内愈的评估.
主要成果:
- Se-He-NLCs表现出受控的第一阶段药物释放,并改善了体外透和体外粘膜粘附.
- 在体内研究表明,增强生物可用性,显著减少氧化应激标志物 (LOOH,MPO) 和增加抗氧化剂水平 (GSH,GST,SOD,CAT).
- Se-He-NLC疗法导致更好的结合比率和优越的愈潜力.
结论:
- 氨酸涂层增强了粘膜粘合性和从NLCs中控制释放hesperidin的特性.
- Se-He-NLCs代表了一种有前途的纳米载体系统,用于有效的胃治疗,改善治疗交付和疗效.
更多相关视频
相关概念视频
Peptic Ulcer Disease IV: Management
94
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
94
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
490
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
490
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
441
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
441
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
485
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
485
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
433
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
433
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
410
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
410


